Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NeoGenomics Inc.

    NASDAQ: NEO · Real-Time Price · USD
    7.40
    0.33 (4.67%)
    At close: Jun 16, 2025, 3:59 PM
    7.37
    -0.41%
    After-hours: Jun 16, 2025, 06:10 PM EDT
    4.67%
    Bid 6.8
    Market Cap 190.47M
    Revenue (ttm) 672.36M
    Net Income (ttm) -77.59M
    EPS (ttm) -0.61
    PE Ratio (ttm) -12.13
    Forward PE 24.63
    Analyst Buy
    Ask 7.73
    Volume 5,444,185
    Avg. Volume (20D) 2,159,536
    Open 7.15
    Previous Close 7.07
    Day's Range 6.84 - 7.40
    52-Week Range 6.08 - 19.11
    Beta 1.64

    About NEO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol NEO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for NEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -2.74%
    NeoGenomics shares are trading lower after Leerink... Unlock content with Pro Subscription
    1 month ago
    -34%
    NeoGenomics shares are trading lower following a Q1 revenue miss.
    news image

    1 day ago · accessnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

    NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ:NEO). Such investors are advised...

    news image

    2 weeks ago · accessnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

    NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ:NEO). Such investors are advised ...

    news image

    2 weeks ago · businesswire.com

    NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

    FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology diagnostics.

    news image

    3 weeks ago · businesswire.com

    NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

    FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the commercial launch of c-MET CDx for NSCLC, its c-MET companion diagnostic immunohistochemistry (IHC) assay.

    news image

    3 weeks ago · businesswire.com

    NeoGenomics to Participate in Upcoming June Investor Conferences

    FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the William Blair Growth Stock Conference in Chicago and the Jefferies Global Healthcare Conference in New York.

    news image

    1 month ago · marketbeat.com

    It's Not Too Late to Jump on These Under-the-Radar Momentum Plays

    Those subscribing to a momentum investing strategy tend to believe that stocks experiencing price increases tend to rally, so long as both internal and external conditions don't change. Of course, no ...

    news image

    1 month ago · businesswire.com

    NeoGenomics Pays Off 1.25% Convertible Senior Notes

    FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics has paid off in full the remaining $201.25 million in principal amount outstanding of its 1.25% Convertible Senior Notes.

    news image

    1 month ago · seekingalpha.com

    NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade)

    NeoGenomics' recent 32.23% stock price decline post-Q1 earnings miss is seen as a buying opportunity due to overreaction and long-term growth potential. Despite a slight revenue miss, the company's lo...

    news image

    1 month ago · seekingalpha.com

    NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript

    NeoGenomics, Inc (NASDAQ:NEO ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Kendra Sweeney - Vice President, Investor Relations and ESG Tony Zook - Chief Executive O...

    news image

    1 month ago · zacks.com

    NeoGenomics (NEO) Reports Break-Even Earnings for Q1

    NeoGenomics (NEO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago.

    Add to Watchlist